Category: Processing
-
Lactalis has acquired Protein Works to deepen its active nutrition position. The deal adds a Liverpool manufacturing base, direct-to-consumer capability, and a stronger platform in high-protein foods.
-
Arkay Zero Proof is preparing French production for European growth. The planned Avignon site will support production, bottling, labelling, logistics, and regulatory preparation for alcohol-free spirits alternatives.
-
ADM’s Berlin flavour centre is supporting faster formulation work. The site brings flavour systems, extracts, speciality ingredients, and application development into one European hub for food and beverage manufacturers.
-
AAK has launched ILLEXAO EN 10 for global enrobed applications. The cocoa butter equivalent is designed to stabilise flow, reduce buildup, and preserve sensory quality at higher substitution levels.
-
DMK has opened lactoferrin capacity at its Altentreptow dairy site. The €25m plant adds specialised milk-protein production, chromatography infrastructure, and commercial supply capability for nutrition, health, and pharmaceutical applications.
-
Melitta is expanding Bremen coffee production through major capital investment. The €100m programme adds roasting, packaging, silo, and process-control capacity to support higher output and product flexibility.
-
Bühler has upgraded chocolate refining and conching systems for processors. The Edition 26 Finer S and ELK S add automation, hygienic design, remote access, and energy-efficiency improvements for tighter mass control.
-
Issue 3 of IN Food is live now for readers. The May/June edition brings together practical insight on packaging, processing, traceability, assurance, and cleaner heat.
-
PPM Technologies and Key Technology have introduced a fully integrated potato chip processing line combining slicing, frying, optical sorting, seasoning, conveying, and production data visibility. The system targets raw-material variability, labour pressure, and high-volume snack production.
-
EPAX Cetoleic 2040 reduced LDL-cholesterol by 7% after eight weeks in a randomised clinical trial of overweight and obese adults, adding human data to the emerging category of marine long-chain monounsaturated fatty acids.